← FDA Drug Approvals (Drugs@FDA)

ANORO ELLIPTA

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2013-12-18

Drug application

FDA Application #

NDA203975

Application type

New Drug Application

Brand name

ANORO ELLIPTA

Generic name

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Active ingredients

UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

Dosage form

POWDER

Route

INHALATION

Marketing status

Prescription

Sponsor

GLAXOSMITHKLINE

Manufacturer

Prasco Laboratories

First approval

2013-12-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown